Liver cancer is one of the most lethal cancers in Africa. Yet its burden and drivers vary widely across different regions. This series of presentations explores key differences between North Africa and Sub-Saharan Africa, focusing on contrasting patterns of incidence, risk factors, and outcomes. Through a regional comparison, the presenters highlight these key factors to provide insights into why these differences matter, and how region-specific prevention and control strategies can help reduce liver cancer mortality across the continent.

This workshop provides advanced training for use of liver point-of-care ultrasonography (POCUS). It is intended for professionals who have previously completed the Basic Skills Liver POCUS course at The Liver Meeting or Digestive Disease Week. The workshop includes a theoretical portion focusing on assessment of inpatient liver findings using POCUS, liver elastography, and advice on implementing liver POCUS in clinical practice. A hands-on session follows with an approach to specific liver findings instead of normal liver anatomy. The workshop concludes with a question-and-answer period.

IMPORTANT NOTE: To register for this session, participants must either be registered for the Basic Skills Liver POCUS Workshop at The Liver Meeting 2026 or have previously completed a Basic Skills Liver POCUS Workshop at The Liver Meeting 2025 or Digestive Disease Week 2026.

This workshop introduces the concept of point-of-care ultrasonography (POCUS) of the liver as an extension of the clinical exam to be performed by hepatology clinicians. Presenters provide a rationale for the use of POCUS, the basics of liver ultrasonography, common applications, and a path to implement POCUS in clinical practice. Participants receive hands-on training for performing POCUS examinations of the liver.

This workshop introduces the concept of point-of-care ultrasonography (POCUS) of the liver as an extension of the clinical exam to be performed by hepatology clinicians. Presenters provide a rationale for the use of POCUS, the basics of liver ultrasonography, common applications, and a path to implement POCUS in clinical practice. Participants receive hands-on training for performing POCUS examinations of the liver.

The "Stump the Hepatologist" session demonstrates the art behind the science of working through the differential diagnosis for cases. Through live interactions with the case presenters, hepatology experts work through interesting and challenging cases and speak aloud about their thought process as the case unfolds. During the process, participants witness how experts in the field, using their knowledge base, break down and narrow their differential diagnosis to solve a case.

Two interesting and challenging cases chosen by the program chairs are presented to hepatology experts. The moderators work to prompt the experts throughout each case to discuss differential diagnoses, work-up, and rationale. Clinical history and labs are presented first followed by more diagnostic tests to allow panelists to arrive at the final diagnosis. Each case is followed by a synopsis and summary/review of the literature of the diagnosis by the case presenter.

This workshop highlights the evolving landscape of cirrhosis diagnosis and management, and explores how these changes are reshaping clinical research. Faculty challenge the traditional approaches to hepatocellular carcinoma (HCC) screening, and portal hypertension assessment and management. Presenters discuss the evolving concept of cirrhosis recompensation with a focus on implications for clinical trial design, end points, and patient stratification. Faculty provide a forward-looking view of cirrhosis research and address key research questions that need to be addressed in the near future. The workshop includes 3 breakout sessions where attendees have the opportunity to interact with experts in smaller groups to discuss clinical research topics of interest, including: (1) noninvasive tools for the management of portal hypertension; (2) recompensation in alcohol-associated liver disease; and (3) the future of HCC screening. 

This workshop highlights the evolving landscape of cirrhosis diagnosis and management, and explores how these changes are reshaping clinical research. Faculty challenge the traditional approaches to hepatocellular carcinoma (HCC) screening, and portal hypertension assessment and management. Presenters discuss the evolving concept of cirrhosis recompensation with a focus on implications for clinical trial design, end points, and patient stratification. Faculty provide a forward-looking view of cirrhosis research and address key research questions that need to be addressed in the near future. The workshop includes 3 breakout sessions where attendees have the opportunity to interact with experts in smaller groups to discuss clinical research topics of interest, including: (1) noninvasive tools for the management of portal hypertension; (2) recompensation in alcohol-associated liver disease; and (3) the future of HCC screening.

In a research environment defined by shifting priorities, tighter budgets, and increasing competition, securing research funding has become more challenging. This practical seminar helps researchers at all career stages navigate these changes and strategically pursue funding opportunities with confidence. Presenters provide attendees with actionable tools for identifying aligned opportunities, strengthening proposal competitiveness, and building partnerships that enhance funding success. This seminar is ideal for both early-career researchers and established researchers seeking resilience and adaptability in today's evolving funding environment.

Join this informative session that features rapid-fire research presentations from investigators funded by the American Association for the Study of Liver Diseases Foundation. Highlighted research topics include: 

• In vivo expansion of gene-targeted hepatocytes for liver gene therapy
• Mechanisms of liver sinusoids adaptation and response to damage
• Metabolic vulnerabilities driving susceptibility to ferroptosis in cholangiocarcinoma
• Artificial intelligence–driven synthetic data generation for enhanced prognostic modeling and clinical trial design in alcohol-associated hepatitis